A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
New England Journal of MedicinePublished 10 December 2004Open access
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin
Citations6,253
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer and could be used as a continuous function to predict distant recurrent in individual patients.
Abstract
The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
NatureMolecular portraits of human breast tumours
16,304 Citations2000Charles M. Perou, Thérese Sørlie +16 more
Variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals were characterized using complementary DNA microarrays representing 8,102 human genes, providing a distinctive molecular portrait of each tumour.
ScienceMolecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
11,622 Citations1999Todd R. Golub, Donna K. Slonim +10 more
A generic approach to cancer classification based on gene expression monitoring by DNA microarrays is described and applied to human acute leukemias as a test case and suggests a general strategy for discovering and predicting cancer classes for other types of cancer, independent of previous biological knowledge.
Proceedings of the National Academy of SciencesGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
10,939 Citations2001Thérese Sørlie, Charles M. Perou +15 more
Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
NatureGene expression profiling predicts clinical outcome of breast cancer
9,608 Citations2002Laura van ‘t Veer, Hongyue Dai +14 more
DNA microarray analysis on primary breast tumours of 117 young patients is used and supervised classification is applied to identify a gene expression signature strongly predictive of a short interval to distant metastases (‘poor prognosis’ signature) in patients without tumour cells in local lymph nodes at diagnosis, providing a strategy to select patients who would benefit from adjuvant therapy.
ScienceQuantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
9,597 Citations1995Mark Schena, Dari Shalon +2 more
A high-capacity system was developed to monitor the expression of many genes in parallel by means of simultaneous, two-color fluorescence hybridization, which enabled detection of rare transcripts in probe mixtures derived from 2 micrograms of total cellular messenger RNA.
New England Journal of MedicineA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
6,520 Citations2002Marc J. van de Vijver, Yudong D. He +19 more
The gene-expression profile studied is a more powerful predictor of the outcome of disease in young patients with breast cancer than standard systems based on clinical and histologic criteria.
Histopathologypathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
6,196 Citations1991C.W. Elston, Ian O. Ellis
The results demonstrate that this method for histological grading provides important prognostic information and, if the grading protocol is followed consistently, reproducible results can be obtained.
New England Journal of MedicineA Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1,471 Citations1989B. Fisher, Joe Costantino +19 more
Tamoxifen significantly reduced the rate of treatment failure at local and distant sites, tumors in the opposite breast, and the incidence of tumor recurrence after lumpectomy and breast irradiation and was attained with a low incidence of clinically appreciable toxic effects.
Journal of Clinical OncologyRevision of the American Joint Committee on Cancer Staging System for Breast Cancer
1,183 Citations2002S. Eva Singletary, Craig Allred +18 more
This revised staging system for breast carcinoma will be officially adopted for use in tumor registries in January 2003 and will be useful for the uniform accrual of outcome information in national databases.
Archives of Pathology & Laboratory MedicinePrognostic Factors in Breast Cancer
1,071 Citations2000Patrick L. Fitzgibbons, David L. Page +12 more
PubMedPrognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
1,024 Citations2000Patrick L. Fitzgibbons, DL Page +12 more
This report constitutes a detailed outline of the findings and recommendations of the consensus conference group, organized according to structural guidelines as defined.
New England Journal of MedicineRules for Making Human Tumor Cells
961 Citations2002William C. Hahn, Robert A. Weinberg
The authors propose a considerably simplified scheme in which only five alterations are required to transform cells from a normal to a malignant phenotype.
JNCI Journal of the National Cancer InstituteNational Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
897 Citations2001Patricia J. Eifel, Jan Axelson +12 more
Adjuvant hormonal therapy should be offered only to women whose tumors express hormone receptor protein in tumor tissues, and quality of life needs to be evaluated in selected randomized clinical trials to examine the impact of the major acute and long-term side effects of adjuvant treatments.
Journal of Clinical Oncology2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
886 Citations2001Robert C. Bast, Peter M. Ravdin +8 more
The updated recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast and colorectal cancers were validated by external review by the American Society of Clinical Oncology's Health Services Research Committee and by ASCO's Board of Directors.
Journal of Clinical OncologyGene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer
620 Citations2005Luca Gianni, Milvia Zambetti +15 more
Quantitative expression of ER-related genes, proliferation genes, and immune- related genes are strong predictors of pCR in women with locally advanced breast cancer receiving neoadjuvant anthracyclines and paclitaxel, suggesting that the patients who are at greatest recurrence risk are more likely to have chemotherapy benefit.
Breast Cancer Research and TreatmentEstrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
582 Citations2002William F. Anderson, Nilanjan Chatterjee +2 more
American Journal Of PathologyMeasurement of Gene Expression in Archival Paraffin-Embedded Tissues
544 Citations2004Maureen Cronin, Mylan Pho +6 more
It is shown that the extent of fragmentation of extracted FPE tissue RNA significantly increases with archive storage time, and this findings support the development of RT-PCR analysis of F PE tissue RNA as a platform for multianalyte clinical diagnostic tests.
JNCI Journal of the National Cancer InstituteTamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
525 Citations1997Bernard Fisher, James J. Dignam +11 more
Findings from this and other NSABP studies indicate that patients with breast cancer who meet NSABP protocol criteria, regardless of age, lymph node status, tumor size, or estrogen receptor status, are candidates for chemotherapy.
Journal of the American Statistical AssociationFlexible Methods for Analyzing Survival Data Using Splines, with Applications to Breast Cancer Prognosis
483 Citations1992Robert J. Gray
In an analysis of a large data set taken from clinical trials conducted by the Eastern Cooperative Oncology Group, these methods are seen to give useful insight into how prognosis varies as a function of continuous covariates, and also into how covariate effects change with follow-up time.
Human PathologyHistological grading of breast carcinomas: A study of interobserver agreement
431 Citations1995Paul Robbins, Sarah E. Pinder +6 more
The similar levels of agreement in training and test sets suggest that reasonable results can be achieved without direct training by expert groups, suggesting that experience and precise grading guidelines are of value.
The LancetTreatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
357 Citations2004Bernard Fisher, Jong‐Hyeon Jeong +5 more
Much benefit has been achieved in treatment of women with oestrogen-receptor-positive tumours and negative nodes and the notion that use of tamoxifen or chemotherapy should be based only on age is too restrictive.
Journal of Clinical OncologyClinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
355 Citations1996
The significant health outcomes identified for use in making clinical practice guidelines (overall survival, disease-free survival, quality of life, lesser toxicity, and cost-effectiveness) were used when data were available.
Journal of Clinical OncologyPostoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
295 Citations1990Bernard Fisher, Carol Redmond +8 more
A better outcome is observed in positive-node breast cancer patients aged greater than or equal to 50 years from the use of postoperative prolonged TAM and short-course AC therapy (completed in 63 days) than from prolonged TAM therapy alone.
Breast Cancer ResearchPrognostic molecular markers in early breast cancer
252 Citations2004Francisco J. Esteva, Gabriel N. Hortobágyi
The role of established molecular markers, as well as potential applications of emerging new technologies, are discussed, including markers of proliferation, hormone receptors, and the human epidermal growth factor receptor 2.
Breast Cancer Research and TreatmentThe relationship between prognostic and predictive factors in the management of breast cancer
158 Citations1998I. Craig Henderson, Anthony J. Patek
Most factors identified to date provide prognostic information, but relatively few provide information that is truly helpful in making a therapeutic decision in the management of individual patients.
CancerPrognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
148 Citations1986Ben W. Davis, Richard D. Gelber +10 more
Tumor grade remained a statistically significant prognostic factor for DPS and overall survival in multivariate analyses controlling for nodal status, tumor size, estrogen receptor status, menopausal status, age, peritumoral vessel invasion, and treatment assigned.
Pathology - Research and PracticeHistological Grading of Breast Cancer
119 Citations1990F Theissig, K D Kunze +2 more
Irrespective of statistically significant differences between the three grades in actuarial survival, the histopathological grading is of rather low value for the prediction of prognosis of individual patients.
Journal of Clinical OncologyExpression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer
107 Citations2005Soonmyung Paik, Steven Shak +8 more
Whether the RS assay predicts prognosis, response to tamoxifen, or both, is determined, and a subset of individual genes (Cyclin B1, Survivin, MYBL2, STK15, Ki-67, PR, and GSTM1), the proliferation gene group score and the RS were significantly associated with DRFS in the placebo pts.
Breast Cancer Research and TreatmentS-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer
68 Citations1998John Bryant, Bernard Fisher +3 more
A well-defined cohort of over 4000 breast cancer patients from National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-14 who had ER-positive tumors and no axillary lymph-node involvement was analyzed, and a strong association was found between S-phase fraction and DFS, as well as survival.
Journal of the American Statistical AssociationFlexible Methods for Analyzing Survival Data Using Splines, With Applications to Breast Cancer Prognosis
68 Citations1992Robert J. Gray
Current Opinion in HematologyMolecular diagnosis of lymphoid malignancies by gene expression profiling
67 Citations2002R. Eric Davis, Louis M. Staudt
Findings underscore the value of gene expression profiling in defining subtypes within the lymphoid malignancies that are molecularly and clinically distinct and argue that this genomic technology should become an integral part of prospective clinical trials.
PubMedObserver variation in histological grading of breast cancer.
42 Citations1989Hopton Ds, J. Thorogood +2 more
A multicentre study was conducted to assess the degree of agreement between pathologists grading breast tumours using the WHO criteria, and satisfactory correlation of grades was found to occur with observer variation.
Journal of Clinical OncologyBreast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.
40 Citations1983Bernard Fisher, D. Lawrence Wickerham +2 more
Values obtained from the tumors of 1,887 patients participating in National Surgical Adjuvant Breast and Bowel Project protocol B-09 have been analyzed to define the distribution of tumor ER or PR according to patient age, the distributionof tumor PR within a specific ER interval, and the concordance of tumorER and PR levels.
European Journal of CancerDo we need prognostic factors in nodal-negative breast cancer?
39 Citations2000Daniel F. Hayes
PubMedNCCN: Breast cancer.
39 Citations2002Robert W. Carlson, S. B. Edge +1 more
The panel believes that participation in high quality clinical trials is the preferred treatment at all points in breast cancer therapy.
Cancer CellCancer Molecular Analysis Project: Weaving a rich cancer research tapestry
23 Citations2002Kenneth H. Buetow, Richard D. Klausner +4 more
The Cancer Molecular Analysis Project of the NCI is integrating diverse cancer research data to elucidate fundamental etiologic processes, enable development of novel therapeutic approaches, and facilitate the bridging of basic and clinical science.
Statistics in MedicineEstimation of the survival function for Gray's piecewise‐constant time‐varying coefficients model
17 Citations2002Z. Valenta, Lisa A. Weissfeld
This work derives a survival function estimator for one important member of the class of TVC models--a piecewise-constant time-varying coefficients (PC-TVC) model and derives an estimate for the variance of the log-transformed and log(-log)-transformed survival function, which leads to estimated confidence limits on the corresponding scales of the survival function.